Back to search

United States· US:55154-3565_3688027d-4234-4b66-824b-a8f16e3e0b18

Dicyclomine Hydrochloride

A dicycloverine product containing dicyclomine hydrochloride, registered in United States by Cardinal Health 107, LLC. The same ATC class is registered in 3 of our 19 countries.

ATC A03AA07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDicyclomine HydrochlorideATCA03AA07REGISTER NO.US:55154-3565_3688027…PACKS LISTED2CHECKEDAugust 23, 2026

Where it is registered

Dicycloverine is registered in 3 of 19 countries.

Countries holding a registration under ATC A03AA07 (dicycloverine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Dicycloverine · ATC A03AA07

3 / 19 countries

  • Canada
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dicycloverine costs, country by country.

Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.

  • United States: $0.62 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Dicycloverine · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • US United States$0.62 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DICYCLOMINE HYDROCHLORIDE
Manufacturer
Cardinal Health 107, LLC
Country
United States (US)
ATC code
A03AA07
ATC class
Dicycloverine
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 23, 2026

Packs & prices · 2

  • ndc11
    5515435650
    10 BLISTER PACK in 1 BAG (55154-3565-0) / 1 CAPSULE in 1 BLISTER PACK
  • ndc11
    55154-3565-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

389 interactions on record for dicycloverine.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dicycloverine · interactions on record

389 records

  • 6 severe
  • 194 moderate
  • 17 minor
  • 172 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dicycloverine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dicycloverine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Dicycloverine, Dicycloverine Focus Pharmaceuticals
  • Latvia · Trigan-Sp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be636c15-43f2-41e2-93dd-9e8896d1581d
GET /v1/drugs/be636c15-43f2-41e2-93dd-9e8896d1581d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "DICYCLOMINE HYDROCHLORIDE",
  "productndc": "55154-3565",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA084285",
  "marketing_category": "ANDA"
}

See everything about dicycloverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.